Business Context and Reporting Period
This Form 8-K is filed by Amedica Corporation (not Sintx Technologies, Inc.) on August 22, 2017. The report addresses a critical corporate governance event regarding the company's listing status on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on regulatory compliance issues rather than financial performance data.
Material Changes and Events
- Delisting Notice: The company received notice from the Nasdaq Listing Qualifications Staff that its securities are subject to delisting due to continued non-compliance with the minimum bid price rule (Rule 5550(a)(2)).
- Bid Price Non-Compliance: The company failed to regain compliance with the $1.00 per share minimum bid price threshold by the August 14, 2017 deadline, despite two 180-day compliance periods.
- Filing Delinquencies: The company remains non-compliant with Nasdaq Listing Rule 5250(c)(1) regarding the timely filing of periodic reports, specifically the Form 10-K for the year ended December 31, 2016, and Forms 10-Q for the quarters ended March 31, 2017, and June 30, 2017.
Outlook, Risks, and Management Commentary
- Appeal Process: Management intends to timely request a hearing before the Nasdaq Hearings Panel to present a plan for regaining compliance. This request will stay any suspension or delisting action pending the hearing outcome.
- Uncertainty: The company explicitly states there can be no assurance that the Panel will grant continued listing or that the company will regain compliance within any granted timeframe.
- Forward-Looking Statements: The filing includes standard cautionary notes that actual results may differ materially from forward-looking statements due to risks and uncertainties.
Investor Verification Checklist
- Verify the current status of the Nasdaq Hearings Panel request and the scheduled hearing date.
- Confirm the filing status of the delinquent Form 10-K (2016) and Forms 10-Q (Q1 and Q2 2017) with the SEC.
- Monitor the daily closing bid price of the common stock to assess progress toward the $1.00 threshold.
- Review the press release dated August 25, 2017 (Exhibit 99.1) for detailed management plans regarding compliance.